Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Drugs of Abuse in Pregnancy

By Howard Roemer, M.D.; William Banner, M.D., PhD; Vern L. Katz, M.D.; and Michael Plinsky, M.D. | on August 1, 2012 | 0 Comment
From the College
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Because of significant implications in pregnancy, consider testing IV drug users for HIV and hepatitis B using the legal principles described below.

You Might Also Like
  • Sepsis in Pregnancy
  • Stroke in Pregnancy
  • Acute respiratory infection in pregnancy
Explore This Issue
ACEP News: Vol 31 – No 08 – August 2012

With cocaine, if abruptio placentae is in the differential (uterine pain, tenderness, vaginal bleeding may or not be present), order a CBC, type and cross for packed RBCs, DIC profile, and ultrasound. Monitor for uterine contractions and fetal heart rate.

Cocaine and Amphetamines

Clinical Presentation

Cocaine or amphetamine (e.g., meth­amphetamine) intoxication may mimic preeclampsia/eclampsia, with elevated blood pressure, muscle twitching, and hyperreflexia.4,5 This may progress to grand mal seizures or status epilepticus. After 20 weeks, consider the possible coexistence of intoxication and preeclampsia/eclampsia.

Spontaneous coronary artery dissection is a rare entity leading to acute coronary syndrome and sudden cardiac death, and therapeutic management options are variable. The literature describes a young patient who presented with ST-elevation myocardial infarction (STEMI) due to coronary artery dissection secondary to cocaine abuse.6

Cocaine is associated with increased risk of placental abruption. Uterine pain, with or without bleeding, should warrant an OB consult. Order a CBC, type and cross for packed RBCs, DIC profile, and ultrasound (which lacks significant sensitivity). Have L&D staff monitor for uterine contractions and fetal heart rate.

Symptom-Specific Treatment

Hypertension, tachycardia. As in nonpregnant patients, hypertension and tachycardia may often respond to benzodiazepine sedation. Be aware that if delivery is imminent, the neonate may have significant sedation from benzodiazepines, so notify the delivery team if they are used.7

For pregnancy beyond 24 weeks, consider that the supine patient may have falsely decreased BP from vena caval compression. Check BP in the left lateral decubitus position to verify numbers. Nitroglycerin can also be used to control hypertension and treat chest pain if needed. This is a reasonable next step after benzodiazepines. After 20 weeks, consider magnesium sulfate to cover preeclampsia/eclampsia.

Nitroprusside is relatively contraindicated secondary to potential fetal cyanide poisoning.

Labetalol, commonly used for hypertension in pregnancy, poses a risk if the patient is cocaine toxic due to more beta- than alpha-adrenergic antagonist effects. The beta-blocking effects should be avoided in this setting.

The role of calcium channel blockers in the treatment of patients with cocaine-associated ACS remains uncertain. Calcium channel blockers should not be used as a first-line treatment but may be considered for patients who do not respond to benzodiazepines and nitroglycerin. Nicardipine is the shortest-acting of the calcium channel blockers.

Phentolamine is an alpha-adrenergic antagonist that may affect vasoconstriction, can be used for severe hypertension, and is considered a second-line agent for chest pain. It appears to increase uterine blood flow.8

Pages: 1 2 3 4 5 | Single Page

Topics: AddictionDiagnosisEmergency MedicineEmergency PhysicianOB/GYNPatient SafetyPharmaceuticalsPregnancy

Related

  • Q&A with ACEP President L. Anthony Cirillo

    November 5, 2025 - 0 Comment
  • November 2025 News from the College

    November 4, 2025 - 0 Comment
  • Overcoming Language Barriers in the Emergency Department

    October 21, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “Drugs of Abuse in Pregnancy”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603